Share This Author
Integrating medical management with diabetes self-management training: a randomized control trial of the Diabetes Outpatient Intensive Treatment program.
DOIT appears to be effective in promoting better diabetes care and positively influencing glycemia and diabetes-related self-care behaviors, however, it demands significant time, commitment, and careful coordination with many health care professionals.
Hospitalization and expenditures for the treatment of general medical conditions among the U.S. diabetic population in 1991.
- N. Ray, M. Thamer, T. Taylor, S. Fehrenbach, R. Ratner
- MedicineThe Journal of clinical endocrinology and…
- 1 October 1996
The disproportionate resources devoted to treating patients with diabetes for conditions that are neither acute glycemic nor chronic complications of diabetes demonstrate the disproportionate resources allocated for in-patient expenditures incurred for the treatment of chronic complications.
Effect of Uric Acid Control on Serum Creatinine.
- T. Yamamoto, John Xie, Zhongze Li, Carey J Field, C. Block, T. Taylor
- MedicineJournal of clinical rheumatology : practical…
- 1 October 2019
A retrospective cohort study of 348 hyperuricemia patients identified in 2015, as having been followed with serial uric acid measurements, finds a significant difference in the least square means of serum creatinine comparing those who achieved an sUa less than or equal to 6.0 mg/dL.
Association between antihypertensive drug use and hypoglycemia: a case-control study of diabetic users of insulin or sulfonylureas.
Efficacy, Safety, and Exposure of Apixaban in Patients with High Body Weight or Obesity and Venous Thromboembolism: Insights from AMPLIFY
- A. Cohen, S. Pan, W. Byon, Bushra S. Ilyas, T. Taylor, Theodore C. Lee
- MedicineAdvances in Therapy
- 22 April 2021
The findings of this post hoc analysis support the use of apixaban in patients with body weight ≥ 120 kg or BMI > 40 kg/m2.
Correction to: Efficacy, Safety, and Exposure of Apixaban in Patients with High Body Weight or Obesity and Venous Thromboembolism: Insights from AMPLIFY
Heart-type Fatty Acid Binding Protein as a Marker of Ischaemia in Patients Undergoing Percutaneous Coronary Intervention
HFABP results were consistent with paired troponin results indicating that it is a marker of cardiac necrosis, indicating the ongoing need for cardiac markers for ischaemia and non-MI events.